AnalystsRoy Buchanan
Roy Buchanan's Stock Forecasts

Analyst Ranking
Top 4%
#188 out of 5084 analysts
Average Return
+43.18%
Win Rate
57%42 out of 74
Risk vs Reward
Poor
Good

Roy Buchanan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Abivax SaABVX
+1,534.64%$6.38$104.29
2025-01-10 -
2025-10-30
Buy
Cidara Therapeutics IncCDTX
+485.24%$18.63$109.03
2025-05-09 -
2025-10-30
Buy
Cidara Therapeutics IncCDTX
+416.24%$21.12$109.03
2025-04-29 -
2025-10-30
Buy
Cidara Therapeutics IncCDTX
+381.05%$22.67$109.03
2025-06-02 -
2025-10-30
Buy
Cidara Therapeutics IncCDTX
+374.04%$23.00$109.03
2025-03-12 -
2025-10-30
Buy

Roy Buchanan Analyst Color

Get additional color on Roy Buchanan's coverage of popular stocks

Roy Buchanan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cidara Therapeutics IncCDTX
8Buy$173.00+58.67%Maintains
a month ago
Assembly Biosciences IncASMB
1Buy$38.00+26.16%Initiates Coverage On
a month ago
Dynavax Technologies CorpDVAX
8Buy$32.00+207.69%Reiterates
2 months ago
Enanta Pharmaceuticals IncENTA
14Buy$25.00+130.20%Maintains
3 months ago
Polypid LtdPYPD
2Buy$14.00+264.58%Maintains
4 months ago
Curevac NvCVAC
9Buy$10.00+86.57%Reiterates
5 months ago
An2 Therapeutics IncANTX
8Buy$2.00+61.29%Maintains
6 months ago
Inovio Pharmaceuticals IncINO
3Buy$18.00+662.71%Reiterates
8 months ago
Esperion Therapeutics IncESPR
3Buy$4.00+40.85%Reiterates
9 months ago
Ironwood Pharmaceuticals IncIRWD
1Buy$14.00+833.33%Maintains
9 months ago
Abivax SaABVX
1Buy$33.00-68.36%Reiterates
10 months ago
Hookipa Pharma IncHOOK
2Buy$7.00+694.55%Maintains
a year ago
Gritstone Bio IncGRTSQ
4Buy$5.00N/AReiterates
a year ago
Arbutus Biopharma CorpABUS
5Buy$5.00N/AMaintains
a year ago
Pardes Biosciences IncPRDS
2Buy$5.00N/AMaintains
3 years ago
Argenx SeARGX
2Buy$448.00N/AMaintains
3 years ago
Cormedix IncCRMD
1Hold$16.00N/AMaintains
3 years ago
Ibio IncIBIO
1Buy$750.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.